Secor Capital Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Secor Capital Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-107,579	Closed	-$1.89M	–	310
2019 Q1	$1.89M	Buy	107,579 +45,331	+73%	+$754K	0.39%	69
2018 Q4	$1.08M	Sell	62,248 -65,085	-51%	-$1.11M	0.14%	209
2018 Q3	$1.9M	Sell	127,333 -52,172	-29%	-$809K	0.21%	153
2018 Q2	$2.85M	Buy	179,505 +16,727	+10%	+$250K	0.24%	132
2018 Q1	$2.29M	Buy	162,778 +59,720	+58%	+$884K	0.19%	182
2017 Q4	$1.44M	Buy	103,058 +24,181	+31%	+$354K	0.06%	242
2017 Q3	$1.13M	Buy	78,877 +3,047	+4%	+$43.5K	0.11%	256
2017 Q2	$1.19M	Buy	+75,830	New	+$1.09M	0.11%	255
2016 Q2	–	Sell	-30,894	Closed	-$637K	–	743
2016 Q1	$637K	Buy	30,894 +18,689	+153%	+$368K	0.09%	269
2015 Q4	$250K	Buy	+12,205	New	+$234K	0.07%	425
2015 Q3	–	Sell	-12,785	Closed	-$238K	–	640
2015 Q2	$238K	Buy	+12,785	New	+$237K	0.09%	342
2015 Q1	–	Sell	-38,638	Closed	-$636K	–	561
2014 Q4	$636K	Sell	38,638 -4,001	-9%	-$68.6K	0.27%	125
2014 Q3	$754K	Buy	+42,639	New	+$838K	0.43%	65
2014 Q2	–	Sell	-22,009	Closed	-$480K	–	334
2014 Q1	$480K	Buy	+22,009	New	+$504K	0.24%	156

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Secor Capital Advisors's VIVO Position: Q2 2019 in Review

Secor Capital Advisors sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 107,579 shares — an estimated $1.89M sold.

Secor Capital Advisors first reported a position in VIVO in Q1 2014 and held it in 14 quarters. The position peaked at $2.85M in Q2 2018. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Secor Capital Advisors reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 107,579 Meridian Bioscience Inc shares in Q2 2019, an estimated $1.89M.
Secor Capital Advisors first reported a position in Meridian Bioscience Inc in Q1 2014 and held it in 14 quarters.
Secor Capital Advisors's Meridian Bioscience Inc position peaked at $2.85M in Q2 2018.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.